Certain gene signaling rewires tumors after immunotherapy

by Anna Megdell,University of MichiganGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2022.12.008Researchers from the University of Michigan Rogel Cancer Center ha

Updated on: January 02,2024

Certain gene signaling rewires tumors after immunotherapy

by Anna Megdell,University of MichiganGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2022.12.008Researchers from the University of Michigan Rogel Cancer Center ha

Updated on:January 02,2024

New marker could detect fatal breast cancer up to one year earlier than current methods

by BioMed CentralMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainA new marker that could be used to diagnose fatal breast cancer up to one year ah

Updated on: March 01,2024

New marker could detect fatal breast cancer up to one year earlier than current methods

by BioMed CentralMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainA new marker that could be used to diagnose fatal breast cancer up to one year ah

Updated on:March 01,2024

Pattern of hospital visits offers clue to spotting people at risk of myeloma

by National Cancer Research InstituteMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0A condition that can progress to myeloma c

Updated on: May 13,2024

Pattern of hospital visits offers clue to spotting people at risk of myeloma

by National Cancer Research InstituteMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0A condition that can progress to myeloma c

Updated on:May 13,2024

Discovery of pancreatic neuroendocrine subtypes could help predict likelihood of recurrence

by Dana-Farber Cancer InstituteCredit: CC0 Public DomainResearchers have discovered two distinct subtypes of pancreatic neuroendocrine tumors—known as pNETs—that have dramatically different risks

Updated on: May 13,2024

Discovery of pancreatic neuroendocrine subtypes could help predict likelihood of recurrence

by Dana-Farber Cancer InstituteCredit: CC0 Public DomainResearchers have discovered two distinct subtypes of pancreatic neuroendocrine tumors—known as pNETs—that have dramatically different risks

Updated on:May 13,2024

Researchers uncovers promising cancer target for liposarcoma

by National University of SingaporeCredit: CC0 Public DomainA study conducted by a team of researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of

Updated on: June 19,2024

Researchers uncovers promising cancer target for liposarcoma

by National University of SingaporeCredit: CC0 Public DomainA study conducted by a team of researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of

Updated on:June 19,2024

Better adenoma detection using a molecular marker for fluorescent imaging

by Sarah E. Glass,Vanderbilt University(a)Representative white light and corresponding fluorescence colonoscopy images (static) of B6;129 mice bearing either colorectal adenomas or normal

Updated on: February 18,2024

Better adenoma detection using a molecular marker for fluorescent imaging

by Sarah E. Glass,Vanderbilt University(a)Representative white light and corresponding fluorescence colonoscopy images (static) of B6;129 mice bearing either colorectal adenomas or normal

Updated on:February 18,2024

Using donor CAR T cells shows promise in treating myeloma patients in phase I trial

by Bob Yirka , Medical XpressCAR T Cell Concentrations Stratified by Response. (a) CAR T cell concentrations among ALLO-715 DL3 patients that received any fludarabine/cyclophosphamide/ALLO-647 (FCA) l

Updated on: February 03,2024

Using donor CAR T cells shows promise in treating myeloma patients in phase I trial

by Bob Yirka , Medical XpressCAR T Cell Concentrations Stratified by Response. (a) CAR T cell concentrations among ALLO-715 DL3 patients that received any fludarabine/cyclophosphamide/ALLO-647 (FCA) l

Updated on:February 03,2024

Research points to potential new treatment for aggressive prostate cancer subtype

byUniversity of MichiganProstate cancer cells. Credit: NIH Image GalleryWhen researchers at the University of Michigan Rogel Cancer Center first identified a new subtype of aggressive prostate c

Updated on: November 11,2024

Research points to potential new treatment for aggressive prostate cancer subtype

byUniversity of MichiganProstate cancer cells. Credit: NIH Image GalleryWhen researchers at the University of Michigan Rogel Cancer Center first identified a new subtype of aggressive prostate c

Updated on:November 11,2024

New tools to manage rare eye cancer

by University College DublinTumor secretion of IL-6, IL-13, VEGF-A, and PlGF correlate with clinical characteristics in ex vivo, control-treated, primary UM patient tumors. (A) Schematic of the e

Updated on: January 29,2024

New tools to manage rare eye cancer

by University College DublinTumor secretion of IL-6, IL-13, VEGF-A, and PlGF correlate with clinical characteristics in ex vivo, control-treated, primary UM patient tumors. (A) Schematic of the e

Updated on:January 29,2024

Researchers identify cell signaling pathways controlling melanoma cell metastasis to the brain

by H. Lee Moffitt Cancer Center & Research InstituteHDAC8 increases the establishment of melanoma brain metastases.a–cHDAC8 and EV expressing WM164 cells were introduced into NOD.

Updated on: June 22,2024

Researchers identify cell signaling pathways controlling melanoma cell metastasis to the brain

by H. Lee Moffitt Cancer Center & Research InstituteHDAC8 increases the establishment of melanoma brain metastases.a–cHDAC8 and EV expressing WM164 cells were introduced into NOD.

Updated on:June 22,2024

Novel therapeutic strategy against melanoma: Combined targeting of hedgehog signaling and BRD4

by Impact Journals LLCCombined targeting of SMO and BRD4 as a potential therapeutic strategy against melanoma. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28441A new editorial paper

Updated on: January 11,2024

Novel therapeutic strategy against melanoma: Combined targeting of hedgehog signaling and BRD4

by Impact Journals LLCCombined targeting of SMO and BRD4 as a potential therapeutic strategy against melanoma. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28441A new editorial paper

Updated on:January 11,2024

Tumor mutations may predict response to immunotherapy

by Johns Hopkins University School of MedicineMismatch repair deficiency refers to a characteristic of some cancer cells that create a large number of mutations, or changes, in certain genes when

Updated on: April 07,2024

Tumor mutations may predict response to immunotherapy

by Johns Hopkins University School of MedicineMismatch repair deficiency refers to a characteristic of some cancer cells that create a large number of mutations, or changes, in certain genes when

Updated on:April 07,2024